Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19
Completed · Not applicable
Conditions studied: Covid19, Pregnancy Related, Maternal Complication of Pregnancy, Coronavirus, Neonatal Infection, Prenatal Stress, Preterm Birth
In brief
Pregnant women are a vulnerable and high-risk population, as COVID-19 is associated with an increased risk preterm birth, cesarean section, and maternal critical care. This study will examine the factors that impede testing for SARS-CoV-2 (the causative virus among pregnant women), help determine optimal testing strategies by evaluating the necessity of testing for asymptomatic disease in pregnancy, inform prenatal care plans by assessing the full impact of infection, and contribute to a provider's ability to counsel women and create prenatal care plans if they are pregnant or considering pregnancy.
Key facts
- Study ID
- NCT04718220
- Run by
- Washington University School of Medicine
- People needed
- 448
- Starts
- 2021-03-01
- Expected to finish
- 2022-11-30
- Last updated by the study team
- 2025-04-03
Who can join
Age: any. Sex: female. Healthy volunteers: accepted.
Where it is running
- Washington University Medical Center — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.